HARBIN, China, March 3 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") , a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced that Mr. Yanqing Liu, the Company's CEO, and Mr. Stanley Hao, CFO, will present at the upcoming Rodman & Renshaw Annual China Investment Conference to be held on March 7-9, 2010.
During the conference, Company management will be available for one-on-one meetings. The Rodman & Renshaw Annual China Investment Conference is a three-day event which features tracks devoted to Healthcare, Metals & Mining, Energy, Clean-tech, Asia, Community & Regional Banks, Growth, & Maritime. For more information about the conference, please visit http://www.rodm.com/conferences .
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .
CONTACT: China Sky One Medical, Inc., Mr. Stanley Hao, CFO, +86-451-
87032617, or stanleyhao@cski.com.cn; or Investor Relations Contact: CCG
Investor Relations, Ms. Lei Huang, Account Manager, +1-646-833-3417, or
lei.huang@ccgir.com; or Ms. Mabel Zhang, Vice President, +1-310-954-1353,
or mabel.zhang@ccgir.com
Web site: http://www.cski.com.cn/
http://www.rodm.com/conferences/
